Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

I disagree. The BP contact mentioned by Panoz1 was correct when he said that BP does not like buying one indication. They’d rather have the whole drug. That’s why Leo took the AlfaSigma deal at such a low price. He wanted to put a win on the board that didn’t compromise Brilacidin’s overall value.

Treatment via enema can used for a very limited number of indications and is easily separable from IV or oral administration. It is also the most risky deal (and therefore worth less) for a BP to make because it is possible that enema administration can be replaced at some point by a time released oral version. It was therefore the proper choice for a deal. It put IPIX in line for some revenue in the short to mid-term timeframes and left the high-dollar indications to mature. So yes, I think Leo has turned his nose up at more than one BP who wanted to get Brilacidin on the cheap.

Grumpy said,

If you look at the Alfasigma deal as an indicator of the kind of deal they will sign, the takeaway is that IPIX will take whatever they can get. They got $400k up front on that deal. I don't see this company turning up their nose at any offer. My opinion is that the offers simply aren't there.

Panoz1 said,

I know a guy that worked at big Pharma negotiating deals. He’s closed >200 Billion dollars worth of deals. I’ve discussed IPIX and B with him at length, and although he’s not a scientist, he liked the story and think it’s got a shot. However, his comment was that BP does not like buying ‘split’ indications for a drug.. they would rather own the whole drug than one indication... “it’s too hard to track”
That said, could this be why Leo’s had so much trouble getting a BP partnership / help / $$$.. IF Leo believes there are multiple billion dollar indications he would want a huge price that’s not justified at this point... and hence the ‘go it alone’ apparent path we’re on.